Evidence map›Paper›PMID 42222828›Full record

ArticleACS omega2026

Injectable Silk Fibroin-Puerarin Hydrogels with Tunable Supramolecular Organization as a Potential Platform for Tissue Engineering.

Bruna V Quevedo, Bianca Sabino Leocádio Antunes, Saeed Safari, David Hubbard, Daniel Komatsu, Menekse Ermis, Eliana Aparecida de Rezende Duek

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bruna V QuevedoPostgraduate Program in Materials Science (PPGCM), Federal University of São Carlos (UFSCar), Sorocaba, SP 18052-780, Brazil.ORCID https://orcid.org/0000-0002-3945-5577
Bianca Sabino Leocádio AntunesPostgraduate Program in Materials Science (PPGCM), Federal University of São Carlos (UFSCar), Sorocaba, SP 18052-780, Brazil.ORCID https://orcid.org/0000-0001-5273-5138
Saeed SafariTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California 91367, United States.
David HubbardTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California 91367, United States.
Daniel KomatsuLaboratory of Biomaterials, Faculty of Medical Sciences and Health (FCMS), Pontifical Catholic University of São Paulo (PUC-SP), Sorocaba, SP 18030-070, Brazil.ORCID https://orcid.org/0000-0002-2441-8650
Menekse ErmisTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California 91367, United States.
Eliana Aparecida de Rezende DuekPostgraduate Program in Materials Science (PPGCM), Federal University of São Carlos (UFSCar), Sorocaba, SP 18052-780, Brazil.ORCID https://orcid.org/0000-0001-6327-7363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Injectable supramolecular hydrogels represent an emerging class of biomaterials with significant potential for minimally invasive tissue engineering and drug delivery applications. In this study, the effects of varying puerarin (PUE, 1-5%) contents, a bioactive isoflavonoid capable of gelation, on the physicochemical and in vitro biological properties of silk fibroin (SF) were systematically evaluated. Hydrogel formation was driven by hydrogen-bonding interactions between SF and PUE, as confirmed by FTIR analysis, without altering the crystalline structure of SF, as evidenced by X-ray diffraction. Microstructural analysis by scanning electron microscopy (SEM) revealed that increasing PUE content progressively reduced pore size and generated a denser polymeric network, resulting in a decrease in swelling capacity. Thermal analyses (TGA/DSC) demonstrated the combined thermal stability and degradation behavior of the resulting system. Rheological characterization showed a marked increase in viscosity and a predominance of storage modulus (

Identifiers

PMID42222828
PMCPMC13216943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.